Keywords: sales, down, glaxo, wellcome, zantac, revenues, tail

Sales Down At Glaxo Wellcome As Zantac Revenues Tail Off

Article | 20 May 1998

Print This

Glaxo Wellcome's announcement at its annual general meeting on May 18that sales for the first four months of 1998 had fallen 7% ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in